D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 67 Citations 17,570 236 World Ranking 4203 National Ranking 1448

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Organic chemistry
  • DNA

His scientific interests lie mostly in Pyrene, Carcinogen, Benzopyrene, Stereochemistry and Diol. His Pyrene research is multidisciplinary, incorporating perspectives in Medicinal chemistry, Mutagen, Phenols, Epoxy and Metabolism. His Carcinogen research incorporates elements of Metabolite, Toxicology and Chrysene.

His research integrates issues of Methylcholanthrene, Toxicity and Chinese hamster in his study of Benzopyrene. The Stereochemistry study combines topics in areas such as Benzophenanthrene, Mouse skin and DNA. His studies deal with areas such as Adduct, Enantiomer and Diastereomer as well as Diol.

His most cited work include:

  • Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease (1345 citations)
  • Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. (1067 citations)
  • Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells (707 citations)

What are the main themes of his work throughout his whole career to date?

Stereochemistry, Pyrene, Diol, Carcinogen and Benzopyrene are his primary areas of study. His study in Stereochemistry is interdisciplinary in nature, drawing from both Adduct, DNA, Deoxyadenosine and Benzophenanthrene. His Pyrene study combines topics in areas such as Medicinal chemistry, Molecular biology, Phenols, Microsome and Metabolism.

Diol is a subfield of Organic chemistry that Haruhiko Yagi explores. His work in Carcinogen addresses subjects such as Monooxygenase, which are connected to disciplines such as Cytochrome. He works in the field of Benzopyrene, focusing on Benzopyrene in particular.

He most often published in these fields:

  • Stereochemistry (44.14%)
  • Pyrene (37.11%)
  • Diol (34.77%)

What were the highlights of his more recent work (between 1997-2012)?

  • Stereochemistry (44.14%)
  • Diol (34.77%)
  • Pyrene (37.11%)

In recent papers he was focusing on the following fields of study:

Haruhiko Yagi focuses on Stereochemistry, Diol, Pyrene, Adduct and Benzopyrene. Haruhiko Yagi interconnects Deoxyguanosine, Oligonucleotide, DNA and Nucleotide in the investigation of issues within Stereochemistry. The Diol study which covers Benzophenanthrene that intersects with Mutagenesis.

His work carried out in the field of Pyrene brings together such families of science as Phenanthrene, Hydrolysis, Urine, Creatinine and A-DNA. Haruhiko Yagi combines subjects such as Chromatography, Polycyclic aromatic hydrocarbon and Carcinogen with his study of Phenanthrene. His Benzopyrene research is multidisciplinary, relying on both Yield and Group.

Between 1997 and 2012, his most popular works were:

  • Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease (1345 citations)
  • Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. (1067 citations)
  • Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells (707 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Organic chemistry
  • DNA

The scientist’s investigation covers issues in Stereochemistry, Pyrene, Adduct, Immune system and Cytotoxic T cell. His Stereochemistry research incorporates themes from DNA polymerase, Base pair and Benzopyrene. His research in Pyrene tackles topics such as Phenanthrene which are related to areas like Chromatography, Carcinogen and Biochemistry.

His Adduct study combines topics in areas such as Diol and Deoxyadenosine. His study with Diol involves better knowledge in Organic chemistry. His study focuses on the intersection of Immune system and fields such as Ovarian cancer with connections in the field of Antibody.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

Shimon Sakaguchi;Masahiro Ono;Ruka Setoguchi;Haruhiko Yagi.
Immunological Reviews (2006)

1899 Citations

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.

Junzo Hamanishi;Masaki Mandai;Masashi Iwasaki;Taku Okazaki.
Proceedings of the National Academy of Sciences of the United States of America (2007)

1637 Citations

Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells

Haruhiko Yagi;Takashi Nomura;Kyoko Nakamura;Sayuri Yamazaki.
International Immunology (2004)

1057 Citations

Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene

M K Buening;P G Wislocki;W Levin;H Yagi.
Proceedings of the National Academy of Sciences of the United States of America (1978)

514 Citations

Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes.

A W Wood;W Levin;A Y Lu;H Yagi.
Journal of Biological Chemistry (1976)

436 Citations

Inhibition of the Mutagenicity of Bay-Region Diol Epoxides of Polycyclic Aromatic Hydrocarbons by Naturally Occurring Plant Phenols: Exceptional Activity of Ellagic Acid

Alexander W. Wood;Mou-Tuan Huang;Richard L. Chang;Harold L. Newmark.
Proceedings of the National Academy of Sciences of the United States of America (1982)

377 Citations

Marked Differences in the Skin Tumor-initiating Activities of the Optical Enantiomers of the Diastereomeric Benzo(a)pyrene 7,8-Diol-9,10-Epoxides

T. J. Slaga;W. J. Bracken;G. Gleason;W. Levin.
Cancer Research (1979)

352 Citations

Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice.

Jaime Kapitulnik;Peter G. Wislocki;Wayne Levin;Haruhiko Yagi.
Cancer Research (1978)

334 Citations

Metabolism of benzo[a]pyrene: conversion of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides

D. R. Thakker;H. Yagi;A. Y.H. Lu;W. Levin.
Proceedings of the National Academy of Sciences of the United States of America (1976)

328 Citations

Metabolism of benzo[a]pyrene. VI. Stereoselective metabolism of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol to diol epoxides.

D.R. Thakker;H. Yagi;H. Akagi;M. Koreeda.
Chemico-Biological Interactions (1977)

318 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Haruhiko Yagi

Franz Oesch

Franz Oesch

Johannes Gutenberg University of Mainz

Publications: 102

Nicholas E. Geacintov

Nicholas E. Geacintov

New York University

Publications: 83

Albrecht Seidel

Albrecht Seidel

Johannes Gutenberg University of Mainz

Publications: 83

Ronald G. Harvey

Ronald G. Harvey

University of Chicago

Publications: 78

Donald M. Jerina

Donald M. Jerina

National Institutes of Health

Publications: 75

Stephen S. Hecht

Stephen S. Hecht

University of Minnesota

Publications: 65

Shantu Amin

Shantu Amin

Pennsylvania State University

Publications: 58

Suse Broyde

Suse Broyde

New York University

Publications: 51

Shimon Sakaguchi

Shimon Sakaguchi

Osaka University

Publications: 47

Hansruedi Glatt

Hansruedi Glatt

Federal Institute for Risk Assessment

Publications: 38

Derek R. Boyd

Derek R. Boyd

Queen's University Belfast

Publications: 34

F. Peter Guengerich

F. Peter Guengerich

Vanderbilt University

Publications: 34

Hasan Mukhtar

Hasan Mukhtar

University of Wisconsin–Madison

Publications: 33

George Coukos

George Coukos

University of Lausanne

Publications: 31

Thomas J. Slaga

Thomas J. Slaga

The University of Texas Health Science Center at San Antonio

Publications: 30

Harry V. Gelboin

Harry V. Gelboin

National Institutes of Health

Publications: 29

Trending Scientists

Raimund Dachselt

Raimund Dachselt

TU Dresden

Chris Brockett

Chris Brockett

Microsoft (United States)

Christopher A. Wiklof

Christopher A. Wiklof

Launchpad Intellectual Property

Stéphane Jobic

Stéphane Jobic

University of Nantes

Angela L. Tyner

Angela L. Tyner

University of Illinois at Chicago

Robert J. Schmitz

Robert J. Schmitz

University of Georgia

Paulo Catry

Paulo Catry

International Sleep Products Association

Otmar Huber

Otmar Huber

Friedrich Schiller University Jena

Moshe Szyf

Moshe Szyf

McGill University

Howard Zalkin

Howard Zalkin

Purdue University West Lafayette

Liurong Fang

Liurong Fang

Huazhong Agricultural University

Ian C. M. MacLennan

Ian C. M. MacLennan

University of Birmingham

Josephine M. Egan

Josephine M. Egan

National Institutes of Health

Arch G. Mainous

Arch G. Mainous

University of Florida

Mario E. Lacouture

Mario E. Lacouture

Memorial Sloan Kettering Cancer Center

Roeland P. van der Marel

Roeland P. van der Marel

Space Telescope Science Institute

Something went wrong. Please try again later.